Proteomics

Dataset Information

0

Trypanosoma brucei global proteome changes upon suramin exposure


ABSTRACT: To understand how suramin kills Trypanosoma brucei, we examined the impact on proteome at different timepoints

INSTRUMENT(S): LTQ Orbitrap Velos, Q Exactive

ORGANISM(S): Trypanosoma Brucei

TISSUE(S): Permanent Cell Line Cell

DISEASE(S): Sleeping Sickness

SUBMITTER: Martin Zoltner  

LAB HEAD: Mark C. Field

PROVIDER: PXD014215 | Pride | 2020-04-30

REPOSITORIES: Pride

altmetric image

Publications

Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes.

Zoltner Martin M   Campagnaro Gustavo D GD   Taleva Gergana G   Burrell Alana A   Cerone Michela M   Leung Ka-Fai KF   Achcar Fiona F   Horn David D   Vaughan Sue S   Gadelha Catarina C   Zíková Alena A   Barrett Michael P MP   de Koning Harry P HP   Field Mark C MC  

The Journal of biological chemistry 20200430 24


Introduced about a century ago, suramin remains a frontline drug for the management of early-stage East African trypanosomiasis (sleeping sickness). Cellular entry into the causative agent, the protozoan parasite <i>Trypanosoma brucei</i>, occurs through receptor-mediated endocytosis involving the parasite's invariant surface glycoprotein 75 (ISG75), followed by transport into the cytosol via a lysosomal transporter. The molecular basis of the trypanocidal activity of suramin remains unclear, bu  ...[more]

Similar Datasets

2024-03-25 | PXD049328 | Pride
2024-03-25 | PXD042022 | Pride
2015-06-05 | E-GEOD-60420 | biostudies-arrayexpress
2015-11-25 | PXD002848 | Pride
2011-04-22 | E-GEOD-28813 | biostudies-arrayexpress
2021-07-02 | PXD025169 | Pride
2019-11-19 | PXD010254 | Pride
2020-12-14 | PXD019389 | Pride
2020-12-14 | PXD019415 | Pride
2020-12-14 | PXD019390 | Pride